LC-MS-based serum fingerprinting reveals significant dysregulation of phospholipids in chronic heart failure
Keywords: ACE-inhibitors; angiotensin-converting-enzyme inhibitors; BNP; B-type natriuretic peptide; BMI; body mass index; CPET; cardiopulmonary exercise test; CRT; cardiac resynchronization therapy; CVD; cardiovascular diseases; FAs; fatty acids; HF; heart failure